Mayne Pharma Group Limited (OTCMKTS:MAYNF – Get Free Report) shares traded up 1.1% during mid-day trading on Thursday. The stock traded as high as $1.87 and last traded at $1.87. Approximately 350 shares traded hands during trading, a decline of 90% from the average session volume of 3,560 shares. The stock had previously closed at $1.85.
Mayne Pharma Group Stock Performance
The company has a 50-day simple moving average of $2.05 and a two-hundred day simple moving average of $1.89.
Mayne Pharma Group Company Profile
Mayne Pharma Group Limited is an Australia-based specialty pharmaceutical company that develops, manufactures, and commercializes branded and generic prescription medicines. Its activities include product development, regulatory support, manufacturing, and the distribution of pharmaceutical products through its own commercial operations and external partners.
The company has focused on therapeutic areas including dermatology, women’s health, and other specialty-care markets. Its portfolio has included prescription products such as oral and topical medicines, as well as contraceptive and other branded therapies.
Further Reading
- Five stocks we like better than Mayne Pharma Group
- Google’s Credit Backstop May Be TeraWulf’s Biggest Advantage
- Could the Midterms Revive Medicare for All? 3 Healthcare Stocks to Watch
- Qualcomm Beat Earnings, But Its Fastest-Growing Businesses Have a Catch
- Oil, Uranium, or Renewables? 3 Energy Plays for a Changing Market
Receive News & Ratings for Mayne Pharma Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Mayne Pharma Group and related companies with MarketBeat.com's FREE daily email newsletter.
